Results 221 to 230 of about 99,225 (351)

Thermoforming for Small Feature Replication in Melt Electrowritten Membranes to Model Kidney Proximal Tubule [PDF]

Marta G. Valverde, Claudia Stampa Zamorano, Dora Kožinec, Laura Benito‐Zarza, Anne Metje van Genderen, Robine Janssen, Miguel Castilho, Andrei Hrynevich, Tina Vermonden, Jos Malda, Mylène de Ruijter, Rosalinde Masereeuw, Silvia M. Mihăilă   +12 more
openalex   +1 more source

Effect of empagliflozin on urinary albumin excretion and hypoxic biomarkers in early diabetic kidney disease: A randomised double‐blind, placebo‐controlled trial

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims The precise mechanism of sodium glucose co‐transporter 2 (SGLT2) inhibitor on reno‐protective effect has been still unclear. In this study, we hypothesised that SGLT2 inhibitor prevents diabetic kidney disease via reduction of hypoxia‐induced factors.
Hisashi Makino, Masato Kasahara, Ryuzo Takashima, Shu Kasama, Naoki Ozu, Hyohun Park, Qingxing Chen, Kazuhiko Tsuruya, Mayu Tochiya, Yoko Omura‐Ohata, Tamiko Tamanaha, Michio Noguchi, Takeshi Aiba, Fumiki Yoshihara, Kiminori Hosoda   +14 more
wiley   +1 more source

JAK inhibitors dampen activation of interferon-activated transcriptomes and the SARS-CoV-2 receptor ACE2 in human renal proximal tubules. [PDF]

iScience, 2021
Jankowski J, Lee HK, Wilflingseder J, Hennighausen L.   +3 more
europepmc   +1 more source

THE POLARITY OF THE PROXIMAL TUBULE CELL IN RAT KIDNEY [PDF]

, 1972
Hans‐G. Heidrich, Rolf Kinne, Eva Kinne‐Saffran, K. Hannig   +3 more
openalex   +1 more source

Effect of preoperative SGLT2 inhibitor use on postoperative acute kidney injury in patients with type 2 diabetes undergoing surgery: A causal inference study using routinely collected data

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To assess whether preoperative sodium‐glucose co‐transporter 2 inhibitor (SGLT2i) use reduces the odds of postoperative acute kidney injury (AKI) in patients with type 2 diabetes undergoing surgery. Methods We conducted a target trial emulation using inverse probability of treatment weighting, utilising routinely collected data from a ...
Frank M. Gao, Kartik Kishore, Dinesh Pandey, Hossein Jahanabadi, Meg Stevens, Ashani Lecamwasam, Leonid Churilov, Elif I. Ekinci   +7 more
wiley   +1 more source

Kir5.1 regulates Kir4.2 expression and is a key component of the 50-pS inwardly rectifying potassium channel in basolateral membrane of mouse proximal tubules. [PDF]

Am J Physiol Renal Physiol
Zhang CB, Ding Z, Duan XP, Chowdhury T, Wang WH, Lin DH.   +5 more
europepmc   +1 more source

Relationship between Para-aminohippurate Secretion and Cellular Morphology in Rabbit Proximal Tubules [PDF]

, 1978
Philip B. Woodhall, C. Craig Tisher, Charles A. Simonton, Roscoe R. Robinson   +3 more
openalex   +1 more source

Effects of sotagliflozin on markers of volume status and sodium handling in patients with type 1 diabetes: A biomarker analysis of the inTandem3 clinical trial

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Sotagliflozin, an inhibitor of sodium‐glucose co‐transporter (SGLT)‐1 and 2, reduces albuminuria, slows GFR decline, and may have diuretic and osmoregulatory effects. The effect of sotagliflozin added to insulin was assessed on markers of neurohormone activation and volume homeostasis in patients with type 1 diabetes (T1D).
Massimo Nardone, Erik Moedt, Hiddo J. L. Heerspink, Michael J. Davies, Manon Girard, David Z. I. Cherney, Marcel H. A. Muskiet   +6 more
wiley   +1 more source

Empagliflozin protects the kidney by reducing toxic ALB (albumin) exposure and preventing autophagic stagnation in proximal tubules. [PDF]

Autophagy
Matsui S, Yamamoto T, Takabatake Y, Takahashi A, Namba-Hamano T, Matsuda J, Minami S, Sakai S, Yonishi H, Nakamura J, Maeda S, Matsumoto A, Matsui I, Yanagita M, Isaka Y.   +14 more
europepmc   +1 more source

Mechanism of water transport accross the renal proximal tubule.

, 1992
B. Corman, Gijs R. van den Brink
openalex   +1 more source